After 40years, new medicine for combating TB
Open Access
- 1 March 2013
- journal article
- Published by Medknow in International Journal of Mycobacteriology
- Vol. 2 (1), 1-2
- https://doi.org/10.1016/j.ijmyco.2013.01.004
Abstract
The International Journal of Mycobacteriology, IranKeywords
This publication has 10 references indexed in Scilit:
- Variations of Subunit ε of the Mycobacterium tuberculosis F 1 F o ATP Synthase and a Novel Model for Mechanism of Action of the Tuberculosis Drug TMC207Antimicrobial Agents and Chemotherapy, 2013
- Randomized Pilot Trial of Eight Weeks of Bedaquiline (TMC207) Treatment for Multidrug-Resistant Tuberculosis: Long-Term Outcome, Tolerability, and Effect on Emergence of Drug ResistanceAntimicrobial Agents and Chemotherapy, 2012
- New Mutations in the Mycobacterial ATP Synthase: New Insights into the Binding of the Diarylquinoline TMC207 to the ATP Synthase C-Ring StructureAntimicrobial Agents and Chemotherapy, 2012
- Safety, Tolerability, and Pharmacokinetic Interactions of the Antituberculous Agent TMC207 (Bedaquiline) With Efavirenz in Healthy VolunteersJAIDS Journal of Acquired Immune Deficiency Syndromes, 2012
- Sterilizing Activity of Novel TMC207- and PA-824-Containing Regimens in a Murine Model of TuberculosisAntimicrobial Agents and Chemotherapy, 2011
- Short-Course Chemotherapy with TMC207 and Rifapentine in a Murine Model of Latent Tuberculosis InfectionAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Bactericidal activity of the diarylquinoline TMC207 against Mycobacterium tuberculosis outside and within cellsTuberculosis, 2010
- The Diarylquinoline TMC207 for Multidrug-Resistant TuberculosisNew England Journal of Medicine, 2009
- Multidrug-resistant and extensively drug-resistantMycobacterium tuberculosis: epidemiology and controlExpert Review of Anti-infective Therapy, 2007
- A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosisScience, 2005